ZONISAMIDE-13C6

Code: z-006-1ml D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

Zonisamide is a second-generation anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures, infantile spasm, mixed s...


 En savoir plus

Votre prix
$435.95 1ML
DEMANDER

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

Zonisamide is a second-generation anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures, infantile spasm, mixed seizure types of Lennox-Gastaut syndrome, and generalized tonic clonic seizure. Zonisamide is marketed in the US under the trade name Zonegran®.

Legal Information

Zonegran is a registered trademark of Dainippon Sumitomo Pharma Co., Ltd.

Snap-N-Spike is a registered trademark of Cerilliant Corporation

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

CERILLIANT is a registered trademark of Cerilliant Corporation

application(s)clinical testing
concentration100 µg/mL in methanol
featureSnap-N-Spike®/Snap-N-Shoot®
formliquid
formatsingle component solution
gradecertified reference material
InChI keyUBQNRHZMVUUOMG-IXSHGPIVSA-N
InChI1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)/i1+1,2+1,3+1,4+1,6+1,8+1
manufacturer/tradenameCerilliant®
packagingampule of 1 mL
Quality Level300
SMILES stringNS(=O)(=O)Cc1no[13c]2[13cH][13cH][13cH][13cH][13c]12
storage temp.−20°C
technique(s)gas chromatography (GC): suitable, liquid chromatography (LC): suitable
Cas Number1435934-68-1
Hazard Class3
Un Number1230
Pack GroupII
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN
GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.